These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2961401)

  • 21. Sustained impairment of pituitary and testicular function in prostatic cancer patients treated with a depot form of a GnRH agonist.
    Rolandi E; Franceschini R; Giberti C; Brancadoro T; Martorana G; Barreca T
    Horm Res; 1988; 30(1):22-5. PubMed ID: 2975631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised, double-blind study of estramustine phosphate and leuprolide acetate.
    De la Grange AB
    Prog Clin Biol Res; 1987; 243B():227-8. PubMed ID: 3116555
    [No Abstract]   [Full Text] [Related]  

  • 23. Early tumor exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone.
    Parmar H; Phillips RH; Lightman SL; Edwards L
    Br Med J (Clin Res Ed); 1985 Dec; 291(6509):1645. PubMed ID: 2934109
    [No Abstract]   [Full Text] [Related]  

  • 24. LHRH analogues in prostatic cancer.
    Lancet; 1986 Feb; 1(8478):445-6. PubMed ID: 2868364
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
    Santen RJ; Warner B
    Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of LHRH agonists in the treatment of advanced cancer of the prostate].
    Fretin J
    Arch Esp Urol; 1990; 43(6):647-9. PubMed ID: 2151155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotrophin-releasing hormone agonists induce osteoporosis.
    Maillefert JF; Sibilia J; Kuntz JL; Tavernier C
    Br J Rheumatol; 1994 Dec; 33(12):1199-200. PubMed ID: 8000764
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative analysis of six months formulation of LHRH analogues for prostate cancer treatment.
    Herranz Amo F
    Arch Esp Urol; 2010 May; 63(4):275-81. PubMed ID: 20508303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term experience in the treatment of advanced prostatic cancer with decapeptyl, compared to orchiectomy.
    De Sy WA; De Wilde P; De Meyer JM; Casselman J; Desmet R; Renders G; Schelfhout W
    Acta Urol Belg; 1988; 56(4):581-8. PubMed ID: 2974680
    [No Abstract]   [Full Text] [Related]  

  • 30. Leuprolide therapy for prostate cancer. An association with scintigraphic "flare" on bone scan.
    Johns WD; Garnick MB; Kaplan WD
    Clin Nucl Med; 1990 Jul; 15(7):485-7. PubMed ID: 2116949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Luteinizing hormone-releasing hormone agonists for treatment of prostatic cancer].
    Gez E
    Harefuah; 1990 Apr; 118(8):483-6. PubMed ID: 2192959
    [No Abstract]   [Full Text] [Related]  

  • 32. Triptorelin to prevent hysterectomy in patients with leiomyomas.
    van Leusden HA
    Lancet; 1988 Aug; 2(8609):508. PubMed ID: 2900426
    [No Abstract]   [Full Text] [Related]  

  • 33. Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancer.
    Kavanagh JJ; Roberts W; Townsend P; Hewitt S
    J Clin Oncol; 1989 Jan; 7(1):115-8. PubMed ID: 2491882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LHRH analogues in the treatment of prostatic cancer. Introduction.
    Dufour B
    Br J Clin Pract Suppl; 1985 Mar; 37():2-3, 14-5. PubMed ID: 3931663
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer.
    Shore ND; Sieber P; Schimke L; Perzin A; Olsen S
    Urol Nurs; 2013; 33(5):236-44, 248. PubMed ID: 24354113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LH-RH agonists in the treatment of pancreatic cancer.
    Gonzalez-Barcena D
    Recent Results Cancer Res; 1992; 124():105-12. PubMed ID: 1535448
    [No Abstract]   [Full Text] [Related]  

  • 37. Decapeptyl in the treatment of advanced prostatic cancer: comparative study with pulpectomy.
    Botto H; Richard F; Mathieu F; Camey M
    Prog Clin Biol Res; 1989; 303():53-60. PubMed ID: 2528740
    [No Abstract]   [Full Text] [Related]  

  • 38. Gonadotrophin releasing hormone analogues for advanced prostate cancer.
    Drug Ther Bull; 1992 Aug; 30(17):65-7. PubMed ID: 1396111
    [No Abstract]   [Full Text] [Related]  

  • 39. [Observations on the course of advanced ovarian cancers following medicamentous reduction of hypophyseal gonadotropins].
    Jäger W; Wildt L; Lang N
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):611-7. PubMed ID: 2528495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction and maintenance of castration by an LHRH analogue: D-Trp6 LHRH or decapeptyl.
    Fretin J; Demerle F; Jardin A
    Prog Clin Biol Res; 1987; 243A():245-7. PubMed ID: 2958855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.